Search Results

You searched for : Neuroblastoma  

Researchers found new Cancer Drug in memory of a 9 year old girl

In a groundbreaking medical breakthrough, a new cancer drug has emerged, inspired by the courage and resilience of a 9-year-old girl. This promising ...
Aug 03

International Childhood Cancer Day 2023 – Awareness, accessible and affordable healthcare

Every 3 minutes, a child dies of cancer. Think about it. This International Childhood Cancer Day, let’s stand united to make childhood cancer a ...
Feb 15

Childhood Cancer Awareness Month 2022 – Together accelerating the cure of cancer in children

Children are blessings from god. We all have unconditional love for our children. And what if, one day you come to know that the child ...
Sep 17

Dr. Priti Mehta a pediatric hematologist oncologist explains the facts about preimplantation genetic diagnosis

...
Jan 21

FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

Y-mAbs Therapeutics today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma....
Nov 26

Y-mAbs’ Nivatrotamab granted Orphan Drug Designation and Rare Pediatric Disease designation by FDA

Researchers at Memorial Sloan Kettering Cancer Center developed nivatrotamab, which is exclusively licensed by MSK to Y-mAbs...
Oct 09

Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers

Headquartered in New Delhi, India, CHP focuses on Africa, Brazil, China, Germany, India, Japan, UK and the USA. Its important areas of work are in ...
Feb 17

Neuroblastoma drug goes through successful drug trials

Aptorum Group Limited , a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in ...
Feb 12

Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the ...
Sep 12

9 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026